Literature DB >> 14982849

Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease.

Ann-Sofie Hansson1, Martina Johannesson, Lars Svensson, Kutty Selda Nandakumar, Dick Heinegård, Rikard Holmdahl.   

Abstract

Relapsing polychondritis is an autoimmune disease that affects cartilage in the ear, nose, and respiratory tract. A pathogenic immune response has been proposed and antibodies to several cartilage proteins are detected in sera from these patients. To investigate the role of the humoral immune response in relapsing polychondritis, we used the matrilin-1-induced relapsing polychondritis model. Mice deficient of B cells (muMT) and mice congenic at the complement factor 5, were immunized with matrilin-1, a cartilage-specific protein mainly detected in the tracheal cartilage. To investigate the binding properties and tissue selection of matrilin-1-specific antibodies we produced matrilin-1-specific B-cell hybridomas. Although 83% of the micro MT heterozygous mice developed respiratory distress and erosive chondritis in the respiratory tract, none of the B-cell-deficient mice were susceptible to disease. In addition, we show that complement factor 5 is important for the induction of matrilin-1-induced relapsing polychondritis. Monoclonal matrilin-1-specific antibodies injected into neonatal mice bound specifically to cartilage of the respiratory tract and adult B-cell-deficient mice injected with the same antibodies developed erosive chondritis in the respiratory tract. We conclude that relapsing polychondritis can be mediated by a pathway involving tissue-specific antibodies and complement activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982849      PMCID: PMC1614711          DOI: 10.1016/S0002-9440(10)63183-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Relapsing polychondritis - pathogenic role of anti-native collagen type II antibodies. A case report with immunological and pathological studies.

Authors:  O Meyer; J Cyna; A Dryll; C Cywiner-Golenzer; M Wassef; A Ryckewaert
Journal:  J Rheumatol       Date:  1981 Sep-Oct       Impact factor: 4.666

2.  Purification and structural characterization of a cartilage matrix protein.

Authors:  M Paulsson; D Heinegård
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

3.  Relapsing polychondritis with positive direct immunofluorescence.

Authors:  W F Bergfeld
Journal:  Arch Dermatol       Date:  1978-01

Review 4.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

5.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

6.  Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.

Authors:  Harald Burkhardt; Tobias Koller; Ake Engström; Kutty Selva Nandakumar; Javier Turnay; Hans G Kraetsch; Joachim R Kalden; Rikard Holmdahl
Journal:  Arthritis Rheum       Date:  2002-09

7.  Antibodies to type II collagen in relapsing polychondritis.

Authors:  J M Foidart; S Abe; G R Martin; T M Zizic; E V Barnett; T J Lawley; S I Katz
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

8.  Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases.

Authors:  R Ebringer; G Rook; G T Swana; G F Bottazzo; D Doniach
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

9.  Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis.

Authors:  J M Stuart; M A Cremer; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen.

Authors:  M A Cremer; J A Pitcock; J M Stuart; A H Kang; A S Townes
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  4 in total

1.  Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage.

Authors:  Changrong Ge; Dongmei Tong; Bibo Liang; Erik Lönnblom; Nadine Schneider; Cecilia Hagert; Johan Viljanen; Burcu Ayoglu; Roma Stawikowska; Peter Nilsson; Gregg B Fields; Thomas Skogh; Alf Kastbom; Jan Kihlberg; Harald Burkhardt; Doreen Dobritzsch; Rikard Holmdahl
Journal:  JCI Insight       Date:  2017-07-06

2.  A case of localized tracheobronchial relapsing polychondritis with positive matrilin-1 staining.

Authors:  Tomonori Makiguchi; Akira Koarai; Chihiro Inoue; Yayoi Aoyama; Taizo Hirano; Takashi Ohe; Tomohiro Ichikawa; Yutaka Shishikura; Hanae Komuro; Yoko Tsukita; Naoki Tode; Tadahisa Numakura; Tsutomu Saito; Teruyuki Sato; Yoshiya Mitsuhashi; Tsutomu Tamada; Hisatoshi Sugiura; Masakazu Ichinose
Journal:  BMC Rheumatol       Date:  2020-01-29

3.  Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients.

Authors:  Mohamed-Yacine Khitri; Alexis F Guedon; Sophie Georgin-Lavialle; Benjamin Terrier; David Saadoun; Julie Seguier; Maelle le Besnerais; Claire De Moreuil; Guillaume Denis; Mathieu Gerfaud-Valentin; Jean Sebastien Allain; Alexandre Maria; Laurence Bouillet; Vincent Grobost; Joris Galland; Olivier Kosmider; Anael Dumont; Mathilde Devaux; Benjamin Subran; Jean Schmidt; Paola Marianetti-Guingel; Sylvain Audia; Sylvain Palat; Marielle Roux-Sauvat; Vincent Jachiet; Pierre Hirsch; Olivier Fain; Arsène Mekinian
Journal:  RMD Open       Date:  2022-07

4.  Critical role of the major histocompatibility complex and IL-10 in matrilin-1-induced relapsing polychondritis in mice.

Authors:  Ann-Sofie Hansson; Asa C M Johansson; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2004-08-12       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.